Showing results (11-20 of 14) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Pediatric Blood & Cancer|May 21, 2021
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effectiveJeremy D Rubinstein, Rachana Shah, Erin H Breese, et al.Pediatric Blood & Cancer|April 15, 2017
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03)Todd M Cooper, Edward Allan Racela Sison, Sharyn D Baker, et al.Pediatric Blood & Cancer|October 2, 2018
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosisArun Gurunathan, Alexander A Boucher, Melissa Mark, et al.Frontiers in Cardiovascular Medicine|July 1, 2024
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group reportKasey J Leger, Michael J Absalon, Biniyam G Demissei, et al.Pageof 2